EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals had revenue of $10.52M in the quarter ending September 30, 2024, a decrease of -30.77%. This brings the company's revenue in the last twelve months to $45.71M, up 7.50% year-over-year. In the year 2023, EyePoint Pharmaceuticals had annual revenue of $46.02M with 11.14% growth.

• Revenue (ttm): $45.71M
• Revenue Growth: +7.50%
• P/S Ratio: 8.46
• Revenue / Employee: $377,793
• Employees: 121
• Market Cap: 611.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	46.02M	4.61M	11.14%
Dec 31, 2022	41.40M	4.47M	12.09%
Dec 31, 2021	36.94M	2.50M	7.27%
Dec 31, 2020	34.44M	14.07M	69.10%
Dec 31, 2019	20.37M	15.79M	345.53%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.